Global Animal Biotechnology Market 2024-2028

Global Animal Biotechnology Market 2024-2028

The animal biotechnology market is forecasted to grow by USD 3654.45 mn during 2023-2028, accelerating at a CAGR of 3.01% during the forecast period. The report on the animal biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing growth strategies of market players, the growing focus on animal cloning, and the use of transgenic animals to produce recombinant proteins.

Technavio's animal biotechnology market is segmented as below:

By Product

• Drugs
• Vaccines
• Diagnostic tests
• Others

By Animal Type

• Livestock/production
• Companion

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing prevalence of animal diseases as one of the prime reasons driving the animal biotechnology market growth during the next few years. Also, emergence of alternatives to animal testing and advancements in R and D for animal biotechnology will lead to sizable demand in the market.

The report on the animal biotechnology market covers the following areas:

• Animal biotechnology market sizing
• Animal biotechnology market forecast
• Animal biotechnology market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading animal biotechnology market vendors that include Anicell BioTech, Bayer AG, Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., EW Group GmBH, Genus Plc, Heska Corp., Hester Biosciences Ltd., IDEXX Laboratories Inc., Ivaoes LLC, Merck and Co. Inc., Neogen Corp., Pfizer Inc., Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., Vimian Group AB, Virbac Group, Z Link Biotech Co. Ltd., and Zeus Biotech Pvt. Ltd.. Also, the animal biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.